Evidence map›Paper›PMID 41149334›Full record

ReviewBiosensors2025

Multiplexed Optical Nanobiosensing Technologies for Disease Biomarker Detection.

Pureum Kim, Min Yu Choi, Yubeen Lee, Ki-Bum Lee, Jin-Ha Choi

Abstract readReview
In one paragraph

Review in Biosensors, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Pureum KimSchool of Chemical Engineering, Clean Energy Research Center, Jeonbuk National University, Jeonju 54896, Republic of Korea.
Min Yu ChoiSchool of Chemical Engineering, Clean Energy Research Center, Jeonbuk National University, Jeonju 54896, Republic of Korea.ORCID 0009-0004-7697-2014
Yubeen LeeSchool of Chemical Engineering, Clean Energy Research Center, Jeonbuk National University, Jeonju 54896, Republic of Korea.
Ki-Bum LeeDepartment of Chemistry and Chemical Biology, Rutgers-The State University of New Jersey, Piscataway, NJ 08854, USA.
Jin-Ha ChoiSchool of Chemical Engineering, Clean Energy Research Center, Jeonbuk National University, Jeonju 54896, Republic of Korea.ORCID 0000-0002-1632-9586

Funding

Jeonbuk National University 2024
6 · The paper itself

Abstract

Most biomarkers exhibit abnormal expression in more than one disease, making conventional single-biomarker detection strategies prone to false-negative results. Detecting multiple biomarkers associated with a single disease can therefore substantially improve diagnostic accuracy. Accordingly, recent research has focused on precise multiplex detection, leading to the development of sensors employing various readout methods, including electrochemical, fluorescence, Raman, and colorimetric approaches. This review focuses on optical sensing applications, such as fluorescence, Raman spectroscopy, and colorimetry, which offer rapid and straightforward detection and are well suited for point-of-care testing (POCT). These optical sensors exploit nanoscale phenomena derived from the intrinsic properties of nanomaterials, including metal-enhanced fluorescence (MEF), Förster resonance energy transfer (FRET), and surface-enhanced Raman scattering (SERS), which can be tailored through modifications in material type and structure. We summarize the types and properties of commonly used nanomaterials, including plasmonic and carbon-based nanoparticles, and provide a comprehensive overview of recent advances in multiplex biomarker detection. Furthermore, we address the potential of these nanosensors for clinical translation and POCT applications, highlighting their relevance for next-generation disease diagnostic platforms.

Indexed as

BiomarkersBiosensing TechniquesColorimetryFluorescence Resonance Energy TransferHumansNanostructuresNanotechnologySpectrum Analysis, RamanBiomarkersbiomarkersdisease diagnosisfluorescence detectionmultiplex detectionnanomaterials

Identifiers

PMID41149334
PMCPMC12562344

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.